A randomized controlled multi-center clinical study on treating children and adolescents with pseudomyopia as Eye-TEAS

Clinical study on the ‘three level prevention and control’ program of integrated traditional Chinese and Western medicine for myopia in children and adolescents

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039783

Enrollment

Unknown

Registered

2020-11-09

Start date

2020-11-10

Completion date

Unknown

Last updated

2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pseudomyopia in children and adolescents

Interventions

Intervention group:TEAS+visual training

Control group:False TEAS+visual training

Eligibility

Sex/Gender

All

Age

6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Age between 6 and 12 years old; 2. Computer optometry before ciliary muscle paralysis: degree from -0.50D; computer optometry equivalent ball lens degree from > -0.50 D after ciliary muscle paralysis: Binocular column mirror degree = 0.50D; 3. Distance and near hidden slope of -12 ~ +12 prismatic degree; 4. No other organic lesions affecting vision in both eyes; 5. Informed consent and voluntary signing of informed consent.

Exclusion criteria

Exclusion criteria: 1. Binocular or monocular combined with corneal, iris, crystal and fundus lesions and other organic lesions affecting vision; 2. Long-term use of external treatment of traditional Chinese medicine treatment, including acupuncture, cupping, massage and moxibustion, ear beans, etc.), corneal shape mirror, hard permeability corneal contact lens, gradual focus more glasses, the periphery from focal control, the focus of many soft contact lens, low concentration of atropine eye drops and visual training related to treatment and is not terminated; 3. Persons with serious systemic diseases, such as cardiovascular, cerebrovascular, liver, kidney, hematopoietic system and mental diseases; Allergic constitution or allergic to medical silica gel; Or mentally ill; 4. Participating in other clinical trials; 5. Meet the diagnosis, but objective conditions can not adhere to the treatment, easy to lose visitors.

Design outcomes

Primary

Measure	Time frame
diopter;Axial length;	—

Secondary

Measure	Time frame
vision;Intraocular pressure;ocular accommodation;	—

Countries

China

Contacts

Public ContactBi Hongsheng

Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine

hongshengbi1@163.com+86 13953113696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026